Tower Research Capital LLC (Trc) Bionomics Limited Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$1.13 - $4.46 $1,753 - $6,921
1,552 Added 2874.07%
1,606 $2,000
Q3 2023

Nov 14, 2023
BUY
$0.95 - $3.37 $51 - $181
54 New
54 $0
Q1 2022

May 12, 2022
SELL
$8.47 - $12.97 $847 - $1,297
-100 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.35 - $14.73 $1,235 - $1,473
100 New
100 $1,000

Others Institutions Holding BNOX

# of Institutions
12
Shares Held
1.64M
Call Options Held
0
Put Options Held
0
View Full List

About BIONOMICS LIMITED

BNOX Quotes by TradingView
  • Ticker BNOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,518,620
  • Market Cap $3.98M
  • Description
  • Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...
More about BNOX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email